Articles
| Open Access |
DOI: Practical Importance Use Of Modern Probiotics In Complex Treatment Of Adenoviral Conjunctivitis
Qumri Islamovna Narzikulova , Doctor Of Medical Sciences, Associate Professor Department Of Ophthalmology Tashkent Medical Academy Tashkent, Uzbekistan Sarvarkhon Akmaljon Ugli Yuldashov , Master Student Department Of Ophthalmology Tashkent Medical Academy Tashkent, Uzbekistan Saida Mamadjanovna Egamberdiyeva , Assistant Department Of Ophthalmology Tashkent Medical Academy Tashkent, Uzbekistan Shokhidakhon Adkhamovna Makhkamova , Master Student Department Of Ophthalmology Tashkent Medical Academy Tashkent, UzbekistanAbstract
Adenoviral conjunctivitis is an inflammatory disease of the conjunctiva that spreads at the epidemic level, the main reason for which is explained by the fact that it is rapidly spread by airborne and domestic routes and has a high degree of contagiousness. In clinical practice, viral eye pathologies develop the background of upper and lower respiratory (especially rhinitis, sinusitis, tonsillitis, bronchitis) and antibiotics are often used to treat bacterial complications in this category of patients. As a result, the balance of the immunomicrobiological environment in the intestines of some patients is disturbed [1,2,7] In this contingent of patients, eye pathologies of viral etiology persist for a long time. In modern practice, an integrated approach is used to increase the effectiveness of the prevention and treatment of adenoviral conjunctivitis. In addition, complex treatment of adenoviral conjunctivitis is required that the adequate use of antiviral and immunomodulatory drugs, as well as the inclusion new group of drugs in the treatment algorithm for increasing effectiveness and eliminate symptoms of this disease [3,5]. Probiotics stimulate the body's specific (antibody and immune system) and non-specific (skin, mucous membranes and tears) immunity by restoring the normal intestinal microflora balance, resulting in activation of cellular and humoral immune processes. The use of modern probiotics during treatment period decreased the production of cytokines in the patient's body in the same time increased of endogenous interferon’s concentration in the blood [1,3,4,6]. Even during an epidemic of adinoviral conjunctivitis, the inclusion of multi-component probiotics such as Bifolak Zincum + C + D3 in the complex treatment plan is effective and safe.
Keywords
Adenoviral conjunctivitis, immunomodulator, Bifolak Zincum C D3
References
Астахов С. Ю. Офтальмологические фтор-хинолоны в лечении и профилактике глазных инфекций / С. Ю. Астахов, А. В. Вохмяков // Клин.офтальмол. – 2008. – Т. 9, № 1.– pp. 28-30
Применение пробиотиков в комплексном лечении HLA-В27-ассоциированных передних увеитах / А. И. Копаенко, Г. Д. Жабоедов, Н. В. Иванова и др. // Филатовские чтения: научно-практич. конференция с международным участием ,посвященная 75-летию основанию института им. В. П. Филатова, 26-27 мая 2011. – Одесса, 2011. – С. 155-156.
Нарзикулова.К.И Разработка и клинико-экспериментальная оценка эффективности комплексного лечения воспалительных заболеваний глазной поерхности / Нарзикулова.К.И / канд. мед. наук, 2014. – Ташкент , 2014. – 18 с.
Шерстюк А. І. Імунологічні та біологіч- ні особливості перебігу аденовірусних кон’юнктивітів та їх лікування / А. І. Шерстюк / Автореф. дис. … канд. мед. наук, 14.01.18. – Київ , 2015. – 18 с.
Майчук Ю. Ф. Современные тенденции в эпидемиологии терапии глазных инфекций / Майчук Ю.Ф. // Окулист. – 2005. – № 6 (74). – С. 8-9.
Fuller R. History and development of probiotics / R. Fuller / Probiotics. The scientific basis. L.: Chapman & Hall, 2012. – P. 1-9.
Sheikn A. K. Topikal antibiotics for acute bacterial conjunctivitis Cochrane systematic rewiew / A. K. Sheikn, A. F. Huwits // Br. Gen. Pract. – 2010. – Vol. 5, No 5. – P. 962-96
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.